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Abstract. Today, Direct-to-Consumer genetic testing services are becoming 
more ubiquitous. Consumers of such services are sharing their genetic and 
clinical information with the research community to facilitate the extraction of 
knowledge about different conditions. In this paper, we build on these services 
to analyse the genetic data of people with different BMI levels to determine the 
immediate and long-term risk factors associated with obesity. Using web 
scraping techniques, a dataset containing publicly available information about 
230 participants from the Personal Genome Project is created. Subsequent 
analysis of the dataset is conducted for the identification of genetic variants 
associated with high BMI levels via standard quality control and association 
analysis protocols for Genome Wide Association Analysis. Finally, we applied 
a combination of Recursive Feature Elimination feature selection and Support 
Vector Machine with Radial Basis Function Kernel learning method to the 
filtered dataset. Using a robust data science methodology our approach provides 
the identification of obesity related genetic variants, to be used as features when 
predicting individual obesity susceptibility. The results reveal that the subset of 
features obtained through Recursive Feature Elimination does not improve the 
performance of the classifier when compared to the totality of genetic variants 
identified in logistic regression. 
Keywords: Bioinformatics, Data Science, Machine Learning, Feature 
Selection, Genetics, Obesity, SNPs. 
1. Introduction 
The global prevalence of obesity has reached epidemic proportions [1]. According to 
the World Health Organization (WHO)
1
, approximately 2.8 million people die each 
year as a consequence of being overweight or obese [2]. Obesity is a major risk for 
other chronic diseases which include diabetes, cardiovascular diseases and cancer [3]. 
The occurrence of obesity has been typically associated with high-income countries 
but nowadays, it is also a rising problem in low and middle-income countries [4]. In 
England, the National Obesity Observatory (NOO) reported that the direct cost to the 
National Healthcare Service (NHS) for treating overweight, obesity and related 
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morbidities increased from £479.3 million in 1998 to £4.2 billion in 2007
2
. The 
effects of obesity are so grave that it reduces life expectancy on average by 3 years – 
in cases of severe obesity this can be between 5 and 13 years [5].  
Advances in Human Genomics have provided significant opportunities and 
research suggests that it might be possible to quantify an individual’s susceptibility to 
obesity from an early age and manage risk as individuals’ progress through life [6]. 
Therefore, combining personalised medicine with genomic information and 
integrating it into medical care and individualised risk assessments will allow us to 
mitigate the long-term effects of obesity and its associated co-morbidities. This is 
being made possible through advances in  bioinformatics [7], data science [8] and 
advanced machine learning algorithms [9].  
This paper explores these ideas further and proposes a robust methodology to 
combine state-of-the-art bioinformatics and data science to investigate genetic 
profiling and risk factor assessment for obesity. We combined two statistical 
approaches for biomarkers evaluation. Risk-Based approach and Classification-Based 
Approach. The first approach is applied to identify statistically significant SNPs 
whilst the second is used to identify a set of SNPs appearing conjointly which can 
serve to predict obesity. The motivation for this research is to identify strong genetic 
markers for use in decision support systems. Data science is utilised to automatically 
build a dataset, using publicly available demographic and genetic information 
provided by individuals. This dataset and subsequent analysis is intended to provide a 
starting point for genetic variants data analysis. 
2. Background 
The decreased costs associated with DNA sequencing have made it easier to access 
genomic data. For example, the 100,000 Genomes Project
3
, conducted by Genomics 
England, has sequenced 100,000 genomes from 70,000 NHS patients suffering with 
rare diseases. The information will be used to create a genomic medicine service for 
the NHS and enable new scientific discovery and medical insights. In the private 
sector, genetic screening services are delivered directly to consumers. Individuals 
simply provide a saliva sample to a Direct-to-Consumer Genetic Testing (DTCGT) 
company and obtain genetic information without any health care provider 
involvement [10]. Many of these DTCGT services use single-nucleotide 
polymorphism (SNP) identification to determine ancestry and genetic markers 
associated with specific diseases with the objective of informing clients about their 
health and how to change behaviours to improve it [10].  
The Personal Genome Project (PGP)
4
 is a non-profit organization created to 
promote the availability and use of personal health information and genome data to 
help accelerate the understanding of genetic variation in humans. While many object 
to privacy, confidentiality and anonymity issues, the PGP believe that sharing such 
data is fundamentally good for science and society. This is a view endorsed by 
members of the public who understand the risks and share their personal information. 
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The founding pilot project of the PGP was initiated by the Harvard Personal Genome 
Project, which now hosts publicly shared genomic and health data from thousands of 
participants. In 2005 information on 10 fully identified individuals was available; 
today, more than 4000 US participants have publicly shared their genomic 
information. There is also evidence that information across initiatives is being shared 
with genetic data from 23andMe appearing in PGP datasets [11]. 
Bioinformaticians routinely extract information from websites using web-
scrapping techniques to obtain content originally presented for human use [12].                                                                                                                        
Collecting this data is tedious and time-consuming. Several institutions have invested 
heavily in data collection, gathering clinical and genetic data within different domains 
for decades. This has resulted in significant amounts of big data [13] and today 
organisations, such as the National Institute of Health (NIH), which sponsored the 
Database of Genomes and Phenotypes (dbGaP), are making this data available to 
interested parties, subject to specific terms and conditions [14]. However, to access 
this data, researchers must follow a data request procedure that can be restrictive to 
general users from other domains that want to make use of genetic data.  
Consequently, other organisations such as the PGP rely on a different strategy defined 
by publicly accessible data that anybody from diverse backgrounds can use to get 
started on genetic analysis. Having access to such repositories has had a huge positive 
impact on the scientific community who no longer need to generate their own data for 
the studies that they conduct.  
Approximately 99.5% of the total number of base pairs (nucleotides) in the human 
genome are identical for any two human individuals [15]. Hence, in genetic 
association studies, bases where there is variation between humans are commonly 
considered. Studies utilizing hypothesis-free methodologies such as genome-wide 
association studies (GWAS) have been used in obesity studies to identify many 
obesity related loci. GWAS, permit the analysis of a large number of genetic variants 
(whole genome) for association with traits of interest. Currently, associations of 
common variants usually should reach threshold levels of P < 5x10
-8
 to be considered 
significant [16]. Conversely, variants with threshold levels of P < 10
-5
 are termed 
suggestive SNPs [17] and could be studied further. The importance of GWAS is 
advancing scientific understanding of disease mechanisms and providing starting 
points and potential opportunities for researchers to improve the development of 
medical treatments. 
Following an open data initiative, genetic association analysis and predictive 
modelling strategies are conducted in this study for the analysis of obesity as a binary 
trait. From data collection to data pre-processing and analysis, this study is intended 
to serve as guide for anybody planning to get started in genetic studies of complex 
diseases such as obesity, using publicly available data.  
3. Materials & Methods 
The dataset used in this paper comprises 230 participants from the PGP, which 
donated genetic data from Direct-to-Consumer genotyping extracted by 23andMe 
[18]. In addition to genetic data, clinical information is also provided. Collected 
contributors are aged between 23 and 79 years of age (average age 46.59) and are all 
from the United States of America. The average height, body mass and BMI of all 
participants is 1.74 meters, 78.97 kg, and 25.97 respectively. Of the total population, 
150 (65.22%) are males and 80 (34.78%) females. The totality of the subjects 
considered in the study reported white as race. This information is summarised in 
Table 1.  
Table 1: Race among participants included in the study.  
Race Gender 
Average 
Age 
Average 
BMI 
Average 
Height (m) 
Average 
Weight (Kg) 
Total 
Participants 
White 
150 Males 
80 Females 
46.59 25.97 1.74 78.97 230  
The following section describes the publicly available data sources that are 
utilised in this study and the processes employed to construct the dataset. 
3.1 Data Collection and Description 
During the initial data collection process, 733 observations/participants and 9 
variables were scrapped from the PGP website
5
. Table 2 provides a description of the 
data fields extracted for each participant.  
The Participant_ID is a unique participant identifier assigned in the PGP. The 
variable Data link provides a URL used to download the genetic profile of each 
participant. In addition, DoB, Gender, Weight, Height, Race, and Blood Type contain 
personal information for each participant. Data about the condition Type 2 diabetes 
(T2D) was also included, although more features based on the existing variables were 
subsequently incorporated to the clinical data file. 
The resulting dataset contained several missing values. Only observations with 
complete values for the variables in Table 2 were retained. Individuals who reported 
being of ethnicities other than white were deleted to avoid population stratification in 
our analysis. This reduced the dataset to 235 observations. The data links for five 
participants were incorrect or information in the download files selected for the 
23andMe data was missing so these were also discarded from the final dataset, 
resulting in 230 individuals.  
Table 2: Variables selected in the web scraping process. 
Variables Description 
Participant ID Participant ID 
Data link Genetic data URL 
DoB Date of Birthday 
Gender Gender 
Weight Weight in Kg 
Height Height in meters 
T2D Type 2 Diabetes 
Race Ethnical background 
Blood Type Blood Type 
Full genome profiles were downloaded in txt format using the variable Data Link 
identified in Table 2. Only full genome data was included in the analysis. In other 
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words, if a participant from the PGP uploaded exonerated data and whole genome 
data to the PGP website, only the whole genome profiles were considered since full 
genome provides complete representation of the genome. The genetic profile of each 
participant contains four variables: rsid, chromosome, position and genotype, and 
several hundred thousand observations that depend on the amount of variants 
discovered by the genotyping process used by 23andMe [18]. The variables included 
in the genetic profiles represent genetic variants or SNPs. 
Downloaded genetic profiles were converted to binary file format [19]. This type 
of format allows for a more efficient and convenient way of manipulating SNP data 
when using open source software for automated GWAS quality control (QC) and 
analysis [19]. Subsequently, all 230 genetic profiles were merged into one main 
binary file (.bim, .bed, .fam). Finally, two main data frames were created – one 
containing the clinical information and the other containing genetic variants identified 
by 23andMe for the 230 participants. 
Additional features were generated using information from existing columns. 
These include body mass index (BMI), constructed from the Weight and Height 
variables and calculated using the metric formula, BMI =
Weight (Kg)
(Height(m))2
. A Status 
feature was also generated from the BMI result. Following the WHO classification for 
BMI
6
, 5 standard weight status categories associated with BMI ranges for adults were 
derived. Table 3, summarizes the number of participants included in each status 
category. The category Normal range has the highest representation among the 
participants (50%) whereas underweight is the category with the lowest representation 
(1.74%). The categories Overweight, Obese and Extremely obese, when grouped 
together, constitute 111 participants. In other words, 48.26% of the participants 
analysed were included in one of these three status categories. Hence, as shown in 
Table 3, two closely balanced classes based on the BMI were created, representing the 
phenotypic variable for risk prediction of obesity. The variables considered in the 
clinical data frame are: Participant_ID, age, gender, height (m), weight (kg), BMI, 
Status, T2D, Race and blood type. 
Table 3: BMI status among participants included in the study. 
Class Status Total number 
Normal 
51.74% 
Underweight 4 
Normal range 115 
Risk 
48.26% 
Overweight 65 
Obese 41 
Extremely obese 5 
3.2 Data Pre-processing  
Analyses was conducted using PLINK and R software. After the data set construction, 
and prior to analysis, data QC was performed. Cases and controls in the present study 
are defined as risk and normal. Following protocols for genetic case-control 
association studies, QC was performed on individuals and then on markers, to 
optimise the number of SNPs remaining in the study [20].  
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In the per-individual QC process, 7 individuals were removed leaving 223 
remining individuals of which, 107 are cases and 116 are controls.  Individuals were 
excluded if they showed abnormal heterozygosity, discordant sex information, were 
duplicated or related individuals, and individuals of divergent ancestry. Strict values 
for missing rate were not considered since most samples in the study would be 
removed. This might be an indicative of poor quality DNA sample [21].  
In the per-marker QC process, SNPs with minor allele frequency (MAF<4%), call 
rate of <98% and deviations from Hardy-Weinberg equilibrium (p<1×10
–3
) were 
excluded. A MAF cut point of 4% is commonly applied in small sample settings [22]. 
After the QC filter process, 722,512 variants and 223 people (145 males and 78 
females) remained for the analyses. 
3.3 Genetic Association Analysis 
For discovery, association analysis on 107 risk cases and 116 controls was performed 
by testing SNPs and individuals that satisfied quality control. Logistic regression was 
used to identify SNPs showing a strong association with the trait of study. However, 
none of the SNPs reached Bonferroni level of significance (p-value < 5×10
-8
) nor 
were suggestive of association (p-value < 1×10
-5
) as shown in Fig. 1. The figure 
illustrates, in the y-axis, the level of statistical significance as measured by the 
negative log of the corresponding p-value, for each SNP. Significant and suggestive 
levels are represented in red and blue respectively. Each typed SNP is indicated by a 
dark-blue or orange dot. In the x-axis, SNPs are arranged by chromosomal location. 
While no SNPs were identified as significant or suggestive, a subset of SNPs with 
p-values < 1×10
-3
 were considered for subsequent analysis as similarly performed in 
[23]. Consequently, a total of 261 SNPs showing the strongest association with the 
phenotype (risk or normal) were considered as features for classification analysis. In 
Fig. 2, SNPs with p-values lower than 10
-3
 are highlighted in green. The red line 
represents the significant level while the blue line indicates the new threshold 
considered (p-values < 1×10
-3
). 
 
Fig. 1. Manhattan plot of genome-wide association analysis results. 
 Fig. 2. Manhattan plot of SNPs considered after suggestive threshold modification.  
4. Feature Selection  
After features were extracted, we explored feature selection to determine which 
features might be the most relevant when discriminating between risk and normal 
classes. Results were compared against those reported when all the features extracted 
from association analysis were considered. 
 Features extracted using logistic regression are represented by two alleles – allele 
1 and allele 2. This means that the real number of features is 522 (261×2). However, 
some of the alleles had missing genotypes for some individuals so we removed them, 
resulting in a final number of 370 alleles (185 SNPs). Additionally, age, gender and 
T2D were also considered in the total set of features. Hence, 185 SNPs and 3 clinical 
variables were evaluated as the total number of features. 
Feature selection is performed using the Recursive Feature Eliminator algorithm 
(RFE), which has been successfully used in the classification of complex diseases 
[24]. Using the RFE algorithm, each feature is assessed to determine its overall rank 
within the dataset. This was performed in a cross-validation loop to find the optimal 
number of features. Cross-validation results using several feature combinations is 
shown in Fig. 3.  
 
Fig. 3. RFE Feature Ranking 
The results indicate that the optimal number of features is 50 as can be observed in 
Table 4. 
Table 4: BMI status among participants included in the study. 
Variables Accuracy Kappa 
1 0.5213 0.03845 
2 0.5361 0.05804 
3 0.5620 0.11923 
4 0.5545 0.09831 
5 0.5774 0.14836 
10 0.6106 0.21792 
15 0.6561 0.31318 
20 0.6837 0.36802 
25 0.6997 0.40093 
50 0.8102 0.62207 
373 0.7959 0.58151 
The 50 ranked features are rs7117995_1, rs2099895_1, rs2180949_1, 
rs4790701_1, rs9285592_1, rs12570718_1, rs9498066_1, rs3913963_1, rs4950524_1, 
rs4746834_1, rs2282033_1, rs10957744_1, rs2884515_1, rs2992453_1, rs535796_1, 
rs12169256_1, rs2383414_1, rs7733733_1, rs17624212_1, rs10869765_1, 
rs1976033_1, rs4690099_1, rs2091626_1, rs2963154_1, rs853184_1, rs9324918_1, 
rs16978131_1, rs42115_1, rs10052957_1, rs852977_1, rs1882421_1, rs6542736_1, 
rs10803491_1, rs9853895_1, rs9857859_1, rs1317243_1, rs9493446_1, rs5006218_1, 
rs258753_1, rs7770717_1, rs1451327_1, rs12106967_1, rs6773206_1, rs927458_2, 
rs2207900_1, rs12595242_1, rs7169313_1, rs7682014_1, rs1446689_1 and 
rs2218724_1. The number after “_” indicates the allele number. 
5. Results 
This section presents the classification results for normal and risk BMI status using 
data scraped from the PGP website. The features extracted after QC and association 
analysis, are used to model a Support Vector Machine with Radial Basis Function 
Kernel (SVM) classifier. Then, the performances when using the subset selected by 
RFE algorithm were compared. The performance is measured using Sensitivity (SE), 
Specificity (SP) and Area Under the Curve (AUC) values. Sensitivities refer to the true 
positive rate (Risk class). Specificities measure the proportion of true negatives 
(Normal class). In this study, it is important to predict risk classes, therefore SE are 
considered higher priority than SP. In binary classification, AUC is an accepted 
performance metric that provides a value equal to the probability that a classifier will 
rank a randomly chosen positive instance higher than a randomly chosen negative one. 
Support Vector Machine is a well-known machine learning algorithm which provided 
the best results in previous experiments using similar data [25]. 
K-fold cross validation is used as a prediction metric with 10 folds and 30 
repetitions. The average performance obtained from 30 simulations is utilized. This 
number is considered, by statisticians, to be an adequate number of iterations to obtain 
an acceptable average. SVM was designed and evaluated using appropriate training 
and testing sets. The selection of hyperparameters to establish an approximately 
optimal configuration for SVM is addressed using Caret for random search parameter 
tuning [26]. Tuning parameters, free parameter of the Gaussian radial basis function 
(sigma) and penalty cost (C), shown in Table 5 produced the models with the best 
ROC values. The table also displays the performance of SVM when the algorithm is 
trained with all features and with the selected features. 
 
The performance for the predictions are reported in Table 6. Similarly, prediction 
results using the entire feature set 373 (370 alleles plus age, gender and T2D) and 
recursive feature selection (50 alleles) are compared. 
 
To illustrate the classifier performance in binary classification, it is particularly 
useful to use the receiver operator characteristic (ROC) curve. It is a convenient way of 
displaying the cut-off values for the false and true positive rates. The ROC curves in 
Fig. 4 illustrates the SE, SP and AUC values in Table 6. In dark blue, the ROC curve 
when all the features are used is represented. Conversely, the red ROC curve represents 
the performance of SVM when the optimal subset of features is selected. The model 
with ROC curve closer to the top left corner show higher performance as the SE and 
SP increase. Therefore, the area under the graph increases as the curve moves away 
from the grey diagonal line towards top left corner of the graph. 
The ROC curve from Fig. 4 shows how using all features allows 100% 
discrimination between the two classes considered in our study. This means that SVM 
can classify normal and risk classes better when using all the features extracted from 
the association analyses.  However, when reducing the dimensionality to fifty features, 
a high AUC value of 97% is achieved.  
Table 5. Training 
 Classifier Sensitivity Specificity AUC 
Best tuning 
parameters 
All Features SVM 0.9687500 0.9830556 0.9985346 
σ = 0.0009165209 
C = 1.020311 
RFE SVM 0.8943056 0.8849537 0.9574788 
σ = 0.01030118 
C = 0.6690987 
Sensitivity, Specificity and AUC values for SVM performance in the training data when 
using all the extracted features and subset selected by RFE. 
Table 6. Prediction 
 Classifier Accuracy Sensitivity Specificity AUC 
All Features SVM 1 1 1 1 
RFE SVM 0.9455 0.9231 0.9655 0.9748 
Sensitivity, Specificity and AUC values for SVM when predicting the two classes 
in the test data, using extracted and selected features. 
 Fig. 4. ROC curve for PGP data when using all (grey) and selected (red) features. 
6. Discussion  
The web-scrapping process applied in this study is susceptible to failures in the future 
if the PGP website structure changes. This is an issue referred to as “medieval torture” 
[27]. The genetic profiles collected from the PGP website included SNPs from whole-
genome sequencing results rather than whole-exome sequencing. Thus, we included a 
wider range of genetic variants in our study, not only SNPs within protein coding 
regions of the DNA. 
PGP dataset is pre-processed via standard QC and association analysis protocols 
for GWAS. Although no SNPs were identified as significant or suggestive, we 
included SNPs with p-values lower than 1×10
-3 
for subsequent analyses as 
accomplished somewhere else [23]. After QC, 722,512 SNPs were considered for 
association and lately reduced to 261 SNPs showing certain level of importance among 
all the variants, using logistic regression.  
Machine learning models suffer from decrease in performance when the number of 
features is excessively high. Using RFE algorithm as a feature selection technique, 323 
features were discarded from the original 373 to be considered to have low 
discriminatory capacity. The remaining 50 features were used to fit a SVM model but 
the results showed lower performance in comparison with those obtained when using 
all features. The total 373 features is a subset with the most relevant variants (also age, 
gender and T2D) obtained after applying QC and logistic analysis to the genetic data 
binary files. These SNPs are highlighted in green in Fig. 2. This could be the reason 
why SVM performs better with 373 features as they include 370 alleles (185 SNPs) 
selected as the strongest associated variants. 
Results in Table 6 indicate that SVM showed the best results with SE=1, SP=1 and 
AUC=1 when the model was trained with all the features extracted from association 
analyses. Reducing the number of features to 50 did not result in an improvement in 
the classifier performance. In addition, SE for SVM when using features selected by 
RFE algorithm is lower than the SP. This result is not encouraging given that 
predicting pathological cases is more important than those that are normal.  
7. Conclusions 
This paper focuses on an approach for selecting informative SNPs from publicly 
available data collected using web scraping techniques. The dataset we created was 
built from research-grade data (that is, not for clinical use), and the conductors of the 
PGP stated that many types of errors are possible. Some of these include errors in the 
data, failure to report or discover significant genetic issues and ambiguous or false 
positive findings. This suggest the utilisation of a more reliable data set in future 
studies, for a solid discovery of genetic risk variants in complex disease prediction. 
A small portion of SNPs that have main effects on obesity as binary trait, has been 
selected after applying QC and association analysis using logistic regression. 
Subsequent analysis applying a Support Vector Machine with Radial Basis Function 
Kernel classifier are conducted for the evaluation of the model in two scenarios. First, 
the algorithm was evaluated using 185 genetic variants (370 alleles) obtained from 
GWAS analysis and 3 clinical variables. Then, results were compared when a subset 
of 50 features were selected using Recursive Feature Elimination algorithm. Even 
though the performance of SVM using the selected features was high, it did not 
improve the performance of the model when using all the 370 features extracted with 
logistic regression. 
While the results show specific genetic variants that could serve as good 
discriminators in the investigation of classification studies, more analysis with a 
higher representation of samples must be carry out.  We propose a set of 50 SNPs to 
be used in future studies as features for the prediction of obesity and other 
comorbidities such as T2D. Genetic variants identified need to be validated and 
contrasted with other studies. Future work will consider the discriminative capacity of 
the SNPs identified in this study evaluated in a more complete dataset. A comparison 
between various feature selection techniques will also be considered. 
References 
1.  James WPT (2008) WHO recognition of the global obesity epidemic. Int J Obes 
(Lond) 32 Suppl 7:S120–S126. doi: 10.1038/ijo.2008.247 
2.  Poloz Y, Stambolic V (2015) Obesity and cancer, a case for insulin signaling. Cell 
Death Dis 6:e2037. doi: 10.1038/cddis.2015.381 
3.  Rao KR, Lal N, Giridharan N V (2015) Genetic & epigenetic approach to human 
obesity. Indian J Med Res 140:589–603. 
4.  Li S, Zhao JH, Luan J, et al (2010) Physical activity attenuates the genetic 
predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective 
population study. PLoS Med 7:1–9. doi: 10.1371/journal.pmed.1000332 
5.  Bello A, Padwal R, Lloyd A, et al (2013) Using linked administrative data to study 
periprocedural mortality in obesity and chronic kidney disease (CKD). Nephrol Dial 
Transplant 28:iv57-iv64. doi: 10.1093/ndt/gft284 
6.  Loos RJF (2012) Genetic determinants of common obesity and their value in 
prediction. Best Pract Res Clin Endocrinol Metab 26:211–226. doi: 
10.1016/j.beem.2011.11.003 
7.  Samish I, Bourne PE, Najmanovich RJ (2014) Achievements and challenges in 
structural bioinformatics and computational biophysics. Bioinformatics 31:146–150. 
doi: 10.1093/bioinformatics/btu769 
8.  Higdon R, Haynes W, Stanberry L, et al (2012) Unravelling the Complexities of Life 
Sciences Data. Big Data 17–23. doi: 10.1089/big.2012.1505 
9.  Tanwani AK, Afridi J, Shafiq MZ, Farooq M (2009) Guidelines to select machine 
learning scheme for classification of biomedical datasets. Lect Notes Comput Sci 
(including Subser Lect Notes Artif Intell Lect Notes Bioinformatics) 5483 LNCS:128–
139. doi: 10.1007/978-3-642-01184-9_12 
10.  Su P (2013) Direct-to-consumer genetic testing: a comprehensive view. Yale J Biol 
Med 86:359–65. 
11.  Ball MP, Bobe JR, Chou MF, et al (2014) Harvard Personal Genome Project: lessons 
from participatory public research. Genome Med 6:10. doi: 10.1186/gm527 
12.  Glez-Pena D, Lourenco A, Lopez-Fernandez H, et al (2014) Web scraping 
technologies in an API world. Brief Bioinform 15:788–797. doi: 10.1093/bib/bbt026 
13.  Marx V (2013) Biology: The big challenges of big data. Nature 498:255–260. doi: 
10.1038/498255a 
14.  Tryka K a., Hao L, Sturcke  a., et al (2014) NCBI’s Database of Genotypes and 
Phenotypes: dbGaP. Nucleic Acids Res 42:D975–D979. doi: 10.1093/nar/gkt1211 
15.  Gonzaga-Jauregui C, Lupski JR, Gibbs RA (2012) Human Genome Sequencing in 
Health and Disease. Annu Rev Med 63:35–61. doi: 10.1146/annurev-med-051010-
162644 
16.  Fadista J, Manning AK, Florez JC, Groop L (2016) The (in)famous GWAS P-value 
threshold revisited and updated for low-frequency variants. Eur J Hum Genet 
24:1202–1205. doi: 10.1038/ejhg.2015.269 
17.  Zhang Y-B, Hu J, Zhang J, et al (2016) Genome-wide association study identifies 
multiple susceptibility loci for craniofacial microsomia. Nat Commun 7:10605. doi: 
10.1038/ncomms10605 
18.  Stoeklé H-C, Mamzer-Bruneel M-F, Vogt G, Hervé C (2016) 23andMe: a new two-
sided data-banking market model. BMC Med Ethics 17:19. 
19.  Purcell S, Neale B, Todd-Brown K, et al (2007) PLINK: A Tool Set for Whole-
Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 
81:559–575. doi: 10.1086/519795 
20.  Anderson C a, Pettersson FH, Clarke GM, et al (2010) Data quality control in genetic 
case-control association studies. Nat Protoc 5:1564–1573. doi: 
10.1038/nprot.2010.116 
21.  Turner S, Armstrong LL, Bradford Y, et al (2011) Quality control procedures for 
genome-wide association studies. Curr Protoc Hum Genet Chapter 1:Unit1.19. doi: 
10.1002/0471142905.hg0119s68 
22.  Reed E, Nunez S, Kulp D, et al (2015) A guide to genome-wide association analysis 
and post-analytic interrogation. Stat Med 34:3769–3792. doi: 10.1002/sim.6605 
23.  GÜL H, AYDIN SON Y, AÇIKEL C (2014) Discovering missing heritability and 
early risk prediction for type 2 diabetes: a new perspective for genome-wide 
association study analysis with the Nurses’ Health Study and the Health Professionals’ 
Follow-Up Study. TURKISH J Med Sci 44:946–954. doi: 10.3906/sag-1310-77 
24.  Li X, Gong X, Peng X, Peng S (2014) SSiCP: a new SVM based Recursive Feature 
Elimination Algorithm for Multiclass Cancer Classification. Int J Multimed 
Ubiquitous Eng 9:347–360. doi: 10.14257/ijmue.2014.9.6.33 
25.  Curbelo Montañez CA, Fergus P, Hussain A, et al (2017) Machine Learning 
Approaches for the Prediction of Obesity using Publicly Available Genetic Profiles. 
In: 2017 Int. Jt. Conf. Neural Networks. Anchorage, Alaska, p 8 
26.  Kuhn M (2008) Building Predictive Models in R Using the caret Package. J Stat Softw 
28:1–26. 
27.  Stein L (2002) Creating a bioinformatics nation. Nature 417:119–120. doi: 
10.1038/417119a 
 
